Dear better: It's always helpful to hear from one who has had personal experience. You point is also well taken that, if a woman has had a hysterectomy for cervical or uterine cancer, a PAP smear scrape of the vaginal cuff should be done. The most current 2012 recommendations suggest a routine vaginal cuff PAP every three years for 20 years after the hysterectomy for cancer was performed.
It is also true that in RARE cases a woman can have a normal PAP which in the following year returns with a high grade or carcinoma in situ result. One always wonders if this was a super aggressive lesion or was missed by the GYN's PAP scrape/pathologist's reading in the prior year.
For other readers, the following are the American College of OB/GYN's 2012 recommendations for PAP smear screening. This list includes only those recommendations which had the strongest evidence to support their use:
---Cervical cancer screening should begin at age 21 years, regardless of the age of sexual initiation or the presence of other behavior-related risk factors.
---Women 21 to 29 years should be tested with cervical cytology studies alone, and screening should be performed every 3 years. Co-testing is not recommended in women younger than 30 years.
---For women 30 to 65 years old, co-testing with cytology and HPV testing every 5 years is preferred.
---Additionally, in women 30 to 65 years old, screening with cytology tests alone every 3 years is acceptable.
---Women who have a history of cervical cancer, have HIV infection, are immunocompromised, or were exposed to diethylstilbestrol in utero should
not follow these routine screening guidelines.
---Both liquid-based and conventional methods of cervical cytology collection are acceptable for screening.
---In women who have had a hysterectomy with removal of the cervix (total hysterectomy)
and have never had CIN 2 or higher, routine cytology screening and HPV testing should be discontinued and should not be restarted for any reason.
---Screening by any modality should be discontinued after age 65 years in women with evidence of adequate negative prior screening results and no history of CIN 2 or higher.
Yours,
Jane